An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study. The results could potentially lead to new therapies ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.

Researchers have unlocked a key in a person's immune response that could halt the spread of cancer the body cannot see.

StudyFirst Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach 21.11.2024 / ...

On "Gulf Coast Life," we discuss the nexus between light pollution and human health, the environment and public safety with ...

As runners count down til Sunday's big race for the Marathon, the cause is driving some people to run 26.2 miles.

BC Cancer, Harvard Medical School and Memorial Sloan Kettering Cancer Center (MSK) have pinpointed what could be the early genetic origins of breast cancer-;cancer-like mutations appearing in the ...

While white Arizonans register the highest cancer rates, Hispanic residents are more likely to die from cancer. Limited ...

ENV-101 aims to address this gap by targeting the Hedgehog pathway, which is implicated in the abnormal wound-healing process ...

NewBiologix, a technology innovation company pioneering tools for efficient, cost-effective, and scalable production of viral vectors for gene and cell therapy, has launched its Xcelltm rAAV ...

You especially notice this when you don't know if you'll get another day. That was true for a Dixon, Illinois man, after his ...